Answers are grounded in this paper and cite their sources.
Here we review data obtained from ganaxolone patient enrollment forms submitted to a specialty pharmacy for patients with cyclin-dependent kinase-like 5 deficiency disorder (CDD), to assess the clinical features of patients being prescribed ganaxolone.
No takes yet. Share an insight, caveat, or question.
Flatt et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: